1 active not recruiting, 1 completed, 1 terminated. 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Terminated 1 |
| Phase 1 | 1 | Active not recruiting 1 |
Follow Sodium Pertechnetate Tc 99m: new trials by email Literature Review of Sodium Pertechnetate Tc 99m trials Research Report on Sodium Pertechnetate Tc 99m
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer Biopsy, Computed Tomography, Fluorine F 18 Tetrafluoroborate - Metastatic Endometrial Carcinoma, Recurrent Endometrial Adenocarcinoma | Phase 1 | Active not recruiting | Mayo Clinic | 34 | 2017-09-15 | 2026-07-21 |
| Sodium Pertechnetate (99Tc) Injection Generator: 99mTc From Neutron-activation 99Mo v 99mTc From Fission 99Mo 99mTc MDP Injection:neutron-bombardment - Cancer of Bone | Phase 3 | Terminated | University of Manitoba | 4 | 2016-08-01 | 2017-10-03 |
| Rubidium-82 PET and Tc-99m-MIBI SPET: A Head to Head Comparison Rubidium-82, Sestamibi. reconstitution with sodium pertechnetate (99mTc) - Coronary Artery Disease | Phase 3 | Completed | Advanced Accelerator Applications | 135 | 2011-02-01 | 2014-05-14 |
Bone Neoplasms (1) · Coronary Artery Disease (1) · Endometrial Neoplasms (1)
Advanced Accelerator Applications (1) · Mayo Clinic (1) · University of Manitoba (1)
Canada (1) · United Kingdom (1) · United States (1)
Jamie N. Bakkum-Gamez, M.D. (1) · Leon Menezes, Dr. (1) · Sandor J Demeter, MSc MD FRCPC (1)
2009 (1), R01CA207240 (1)